Filing Details
- Accession Number:
- 0000899243-22-014088
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-04-06 16:30:30
- Reporting Period:
- 2022-04-04
- Accepted Time:
- 2022-04-06 16:30:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1402479 | Medavail Holdings Inc. | MDVL | Retail-Drug Stores And Proprietary Stores (5912) | 900772394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1668029 | Fan Yu | Unit 3002-3004, 30Th Floor Gloucester Tower, The Landmark, Central Hong Kong K3 | No | No | Yes | No | |
1808684 | Ally Bridge Group-Wtt Global Life Science Capital Partners, L.p. | Unit 3002-3004, 30Th Floor Gloucester Tower, The Landmark, Central Hong Kong K3 | No | No | Yes | No | |
1822947 | Ally Bridge Group (Ny) Llc | 430 Park Avenue, 12Th Floor, New York NY 10022 | No | No | Yes | No | |
1831963 | L.p. Fund Master Medalpha Bridge Ally | 430 Park Avenue, 12Th Floor, New York NY 10022 | No | No | Yes | No | |
1832106 | Ltd. Management Abg | Unit 3002-3004, 30Th Floor Gloucester Tower, The Landmark, Central Hong Kong K3 | No | No | Yes | No | |
1832108 | Ltd Gp Partners Capital Science Life Global Abg-Wtt | Unit 3002-3004, 30Th Floor Gloucester Tower, The Landmark, Central Hong Kong K3 | No | No | Yes | No | |
1832109 | Abg-Wtt Global Life Science Capital Partners Gp, L.p. | Unit 3002-3004, 30Th Floor Gloucester Tower, The Landmark, Central Hong Kong K3 | No | No | Yes | No | |
1832110 | Ltd Wtt-Medavail Abg | Unit 3002-3004, 30Th Floor Gloucester Tower, The Landmark, Central Hong Kong K3 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-04-04 | 11,143,529 | $1.06 | 15,029,480 | No | 4 | P | Indirect | See footnote |
Common Stock | Acquisiton | 2022-04-04 | 2,974,117 | $1.06 | 5,894,897 | No | 4 | P | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See footnote |
No | 4 | P | Indirect | See footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrant (Right to Buy) | Acquisiton | 2022-04-04 | 5,571,764 | $1.06 | 5,571,764 | $1.25 |
Common Stock | Warrant (Right to Buy) | Acquisiton | 2022-04-04 | 1,487,058 | $1.06 | 1,487,058 | $1.25 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
5,571,764 | 2022-04-04 | 2027-04-04 | No | 4 | P | Indirect |
1,487,058 | 2022-04-04 | 2027-04-04 | No | 4 | P | Indirect |
Footnotes
- These securities are held of record by ABG WTT-MedAvail Limited ("ABG WTT"). ABG WTT is wholly owned by Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. Voting and investment decisions with respect to any securities held of record by ABG WTT are made by the investment committee of ABG-WTT Global Life Science Capital Partners GP Limited, which is the general partner of ABG-WTT Global Life Science Capital Partners GP, L.P., which is the general partner of Ally Bridge Group-WTT Global Life Science Capital Partners, L.P. As such, each of the foregoing entities may be deemed to share beneficial ownership of the shares held by ABG-WTT. Each of them disclaims any such beneficial ownership.
- These securities are held of record by Ally Bridge MedAlpha Master Fund L.P. ("MedAlpha"). Mr. Fan Yu is the sole shareholder of ABG Management Ltd., which is the sole member of Ally Bridge Group (NY) LLC, which manages MedAlpha's investments. As such, each of the foregoing entities and Mr. Fan Yu may be deemed to share beneficial ownership of the shares held of record by MedAlpha. Each of them disclaims any such beneficial ownership.As a result of an internal reorganization, Ally Bridge MedAlpha Management L.P. and Ally Bridge MedAlpha Management GP, LLC are no longer deemed to share beneficial ownership of the securities reported herein.